Godrej Agrovet Limited has informed the Exchange regarding a press release dated August 06, 2025, titled "Press Release for the Quarter ended June 30, 2025".
GODREJAGRO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godrej Agrovet reported Q1 FY26 consolidated revenues of ₹2,614 crore, up 11.2% YoY from ₹2,351 crore. EBITDA grew 19.6% to ₹282 crore with margin expansion to 10.8% (vs 10.0% in Q1 FY25), and PAT rose 13% to ₹149 crore. Growth was driven by strong performance in the Vegetable Oils business (higher CPO and PKO realizations, with Fresh Fruit Bunch arrivals up 52% YoY) and a significant reduction in losses at Astec Lifesciences, where revenue grew ~31%. Animal Feed volumes grew a healthy 8% but segment revenue was flat due to lower realizations. Dairy and Poultry segments faced headwinds from early rains and higher milk procurement costs, while the Bangladesh JV (ACI Godrej) posted ~20% revenue de-growth in local currency. A new maize herbicide 'Ashitaka' was launched in July 2025.
Solid top-line growth with margin expansion is a positive for shareholders, supported by operational improvement and a turnaround at Astec. However, mixed segment performance (weak Dairy, Poultry, and Bangladesh JV) and flat Animal Feed realizations suggest the rally may not be uniform across businesses.